Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - CHANGE IN WORKING CAPITAL
Change in Working Capital HALO - Halozyme Therapeutics, Inc.
-89.3 M
LAST VALUE
-1.92%
2 YEAR CAGR
-12.05%
5 YEAR CAGR
-96.15%
10 YEAR CAGR